The past, present and future of angiotensin II type 2 receptor stimulation.
about
Rational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptorsRole of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker ratsAngiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury.N-Aryl Isoleucine Derivatives as Angiotensin II AT2 Receptor Ligands.A vascular piece in the puzzle of adipose tissue dysfunction: mechanisms and consequences.Effects of cardiac overexpression of the angiotensin II type 2 receptor on remodeling and dysfunction in mice post-myocardial infarctionDistribution of non-AT1, non-AT2 binding of 125I-sarcosine1, isoleucine8 angiotensin II in neurolysin knockout mouse brainsDiscovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.Angiotensin II increased neuronal stem cell proliferation: role of AT2R.Angiotensin type 2 receptors: blood pressure regulation and end organ damageSaralasin and Sarile Are AT2 Receptor Agonists.Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studiesAngiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?Small-molecule AT2 receptor agonists.The Angiotensin II Type 2 Receptor in Brain Functions: An Update.Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium.Postprandial fatty acid uptake and adipocyte remodeling in angiotensin type 2 receptor-deficient mice fed a high-fat/high-fructose diet.AT(2) receptor and tissue injury: therapeutic implications.Emerging drugs which target the renin-angiotensin-aldosterone system.The regenerative potential of angiotensin AT2 receptor in cardiac repair.How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Steroidogenesis-adrenal cell signal transduction.Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014).PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review.Regulation of zonation and homeostasis in the adrenal cortex.Identification and characterization of CD4(+)AT2(+) T lymphocyte population in human thoracic aortic aneurysm.Stimulation of the Angiotensin II AT2 Receptor is Anti-inflammatory in Human Lipopolysaccharide-Activated Monocytic Cells.Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats.AT2 Receptor-Interacting Proteins ATIPs in the Brain.Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer.
P2860
Q27023787-71828BDD-0EAE-4A81-BF0A-094D3D3CDDC5Q28571720-5A9C7465-2383-4789-ABCC-A8E5C4FDC660Q30585823-AE82DEF0-1E9E-4131-8B31-5D106EE78FABQ31160630-0917B597-8C9E-4BB1-B7FA-7B5E9F4E2980Q33356605-B3F165BF-7184-47B9-BD5A-5D9EF32AE8C3Q33650781-D05DC06D-7608-4B58-B3E8-8369C0137A8CQ34078729-6395EEE5-0988-47AC-B49E-8235174CE809Q34543485-C3A1B31B-150C-4DC3-B420-D3736BBD8E5BQ34730534-5F97764B-BC44-44BE-94F1-5E477E964A45Q35236405-8D7457FB-BF09-4F79-AB4F-1A19AD63AD3EQ35329815-41E0DBFB-BBE2-4AD2-AC0B-30BD66137011Q35786784-7CB72104-E24E-4652-9ACA-44FBF3F96553Q35971305-5A82C2BF-2864-4D11-87E1-EEB4C06A2BBDQ36400573-A23D9C77-DF30-45DD-BE4D-D3D6B940EC50Q36520049-F8E8C3F2-D924-43E1-9BFE-C267977EA58AQ36565868-9C9D6FDA-EF37-4BB9-A8DA-E56196FEC2B3Q36812416-82CEFE5A-DD99-4ABD-96EE-3AA74C3138ECQ37531017-8783DA19-FDCB-4954-953E-F0F462B7ABD1Q37929786-694B5075-EE15-439E-B492-8085457B44FFQ37988002-447985F3-8B84-4E2A-AD33-C27295A959FEQ38069825-C349D6E7-1855-43FC-997E-D4F24FBE33BDQ38217456-24A76D33-F577-4771-AAA0-11DA3C0A30A0Q38221447-4AFEBF6F-180F-4D59-A6A5-1044B2FCCC6EQ38546917-3F672BD6-89D8-44B8-9F17-449240029FFFQ38861206-8897A8D3-5BC5-480C-97F5-3165F1F752FCQ38952304-90A919AF-E43C-43C7-A8BC-184E696AFFB3Q39686130-92C745DC-438F-4F67-9D87-5374E5FDF44AQ41251046-311DA9B0-69BA-4840-A739-DD5A2A3D9E71Q41818299-D902D4DF-0EC7-4337-A4C4-A29C778136D2Q42154092-ED915A31-34B3-45BA-A9A1-07CE2607D6ABQ43880703-D21EED20-7CC2-43B9-8900-E92AD262A48A
P2860
The past, present and future of angiotensin II type 2 receptor stimulation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The past, present and future of angiotensin II type 2 receptor stimulation.
@en
The past, present and future of angiotensin II type 2 receptor stimulation.
@nl
type
label
The past, present and future of angiotensin II type 2 receptor stimulation.
@en
The past, present and future of angiotensin II type 2 receptor stimulation.
@nl
prefLabel
The past, present and future of angiotensin II type 2 receptor stimulation.
@en
The past, present and future of angiotensin II type 2 receptor stimulation.
@nl
P2860
P50
P356
P1476
The past, present and future of angiotensin II type 2 receptor stimulation.
@en
P2093
Aleksandra Grzesiak
Franziska Rompe
P2860
P356
10.1177/1470320309347791
P577
2009-10-27T00:00:00Z